Viridian Therapeutics
Tricia Nguyen, PhD, is a seasoned scientist currently serving as a Senior Associate Scientist at Viridian Therapeutics, Inc., where responsibilities include in vitro diagnostic work for monoclonal antibody therapeutics aimed at thyroid eye disease and autoimmune conditions, alongside expertise in scientific communication for investor relations and publications. Previously, Tricia completed a doctoral degree at the University of Colorado Boulder, focusing on live cell imaging, molecular biology, and developing nanobody libraries while mentoring junior scientists and publishing in high-impact journals. Earlier experience includes roles as a Research Associate at Inovio Pharmaceuticals, where Tricia characterized DNA-based cancer vaccines, and at UC Irvine, where Tricia studied cancer metabolism and sphingolipid-derived drugs. Education includes a PhD in Molecular, Cellular, & Developmental Biology from the University of Colorado Boulder and a Bachelor of Science in Pharmaceutical Sciences from UC Irvine.
Viridian Therapeutics
2 followers
Viridian is dedicated to improving patients’ lives through the discovery and development of RNA-based therapeutics, with a specific focus on microRNAs.